Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | CTSD | P07339 | 5/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7270130 | 0.98 | CA2 (0.64) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL6449063 | 0.98 | CA2 (0.69) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL6445023 | 0.98 | CA2 (0.69) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL9227910 | 0.98 | CA2 (0.69) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL6447680 | 0.98 | CA2 (0.69) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL7343161 | 0.98 | CA2 (0.69) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL7330979 | 0.95 | CA2 (0.61) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL7330634 | 0.94 | CA2 (0.59) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL7333160 | 0.94 | CA2 (0.59) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL7331875 | 0.93 | CA2 (0.58) | CA2CTSDSMN1; SMN2CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0402646-B1 | Retroviral protease inhibiting compounds | ABBOTT LAB (US) | 1998-07-22 | — | — | EP | claimed |
| JP-3128335-A | — | — | None | — | — | JP | disclosed |
| EP-0402646-B1 | Retroviral protease inhibiting compounds | ABBOTT LAB (US) | 1998-07-22 | — | — | EP | disclosed |
| EP-0839798-A2 | Intermediates for preparating non-peptide retroviral protease inhibitors | ABBOTT LABORATORIES (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5670675-A | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1997-09-23 | — | — | US | disclosed |
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |
| JP-H03128335-A | RETROVIRAL PROTEASE INHIBITOR | ABBOTT LAB | 1991-05-31 | — | — | JP | disclosed |
| EP-0402646-A1 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-12-19 | — | — | EP | disclosed |